Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medical Care


Press Releases

IceCure System Successfully Treated Kidney Cancer Tumor with 92% Disease-Free Survival Rate and...

  Nov 28, 2023

Martha Stewart CBD Debuts New Need-Based Gummies Targeting Sleep, Stress, and Discomfort

  Nov 29, 2023

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe...

  Nov 29, 2023

CloudMD Announces Third Quarter Earnings Date

  Nov 28, 2023

CloudMD Reports Third Quarter 2023 Financial Results; Company Delivers Early on Commitment to be...

  Nov 29, 2023

ZYUS Life Sciences Corporation Reports Q3 2023 Results

  Nov 29, 2023

1933 Industries Reports Fourth Quarter and 2023 Year-End Financial Results and Posts Record...

  Nov 28, 2023

ROSEN, LEADING INVESTOR COUNSEL, Encourages DocGo Inc. Investors to Secure Counsel Before Importa...

  Nov 29, 2023

Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common...

  Nov 29, 2023

Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement

  Nov 29, 2023

Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit

  Nov 29, 2023

Cansortium Reports Third Quarter 2023 Results

  Nov 29, 2023

Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program...

  Nov 28, 2023

Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider

  Nov 29, 2023

Jushi Holdings Inc. Announces Filing of Preliminary Base Shelf Prospectus

  Nov 29, 2023

StateHouse Reports Third Quarter 2023 Financial Results

  Nov 29, 2023

Rite Aid Helps Customers Prioritize Immunity During Busy Holiday Season with Flu Shot Fridays

  Nov 29, 2023

Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the...

  Nov 29, 2023

Theralase Release's 3Q2023 Interim Financial Statements

  Nov 29, 2023

Theralase(R) Closes $CAN 1.17 Million Non-Brokered Private Placement

  Nov 29, 2023

Therma Bright Prepares FDA 513(g) Review Document for its AI-Driven Digital Cough Analyzer (DCA)

  Nov 29, 2023

Reliq Health Technologies, Inc. Provides Update on Status of Management Cease Trade Order

  Nov 28, 2023

Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering

  Nov 29, 2023

Cogent Biosciences Announces Poster Presentations at Upcoming San Antonio Breast Cancer Symposium

  Nov 29, 2023

Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include...

  Nov 29, 2023

FDA Accepts Arcutis' Supplemental New Drug Application for Roflumilast Cream 0.15% for the...

  Nov 29, 2023

INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+...

  Nov 29, 2023

Gain Therapeutics to Participate in AI Driven Drug Discovery Summit

  Nov 29, 2023

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding...

  Nov 29, 2023

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP...

  Nov 29, 2023

Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023

  Nov 29, 2023

Xenon Pharmaceuticals Announces Proposed Public Offering

  Nov 29, 2023

Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference

  Nov 29, 2023

Precigen to Participate in the JMP Securities Hematology and Oncology Summit

  Nov 29, 2023

Acelyrin (SLRN) Faces Lawsuit after Allegedly Lying About Drug Candidate's Progress-Hagens Berman

  Nov 29, 2023

MDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Veradigm Inc. Investors...

  Nov 29, 2023

uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene...

  Nov 29, 2023

Cytokinetics Announces Five Presentations at the 34th International Symposium on ALS/MND

  Nov 29, 2023

ROSEN, A LEADING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc....

  Nov 29, 2023

Arrowhead Pharmaceuticals Reports Fiscal 2023 Year End Results

  Nov 29, 2023

BeiGene to Host ASH Investor Meeting in Person and via Webcast on December 10, 2023

  Nov 29, 2023

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly...

  Nov 29, 2023

Ocugen CEO to Present at NobleCon19 - Noble Capital Markets' Nineteenth Annual Emerging Growth...

  Nov 29, 2023

Pasithea Therapeutics Announces Adjournment of 2023 Annual Meeting of Stockholders

  Nov 29, 2023

Mainz Biomed's Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made...

  Nov 29, 2023

The Law Offices of Frank R. Cruz Announces Investigation of Eagle Pharmaceuticals, Inc. (EGRX) on...

  Nov 29, 2023

Eagle Pharmaceuticals Announces Management Change

  Nov 29, 2023

SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a...

  Nov 29, 2023

Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology...

  Nov 29, 2023

G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium

  Nov 29, 2023

Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis...

  Nov 29, 2023

Alpha Tau to Participate in Sidoti Small-Cap Conference

  Nov 29, 2023

Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on December 7, 2023

  Nov 29, 2023

Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human...

  Nov 29, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Entrada Therapeutics, Inc. - TRDA

  Nov 29, 2023

SELLAS Life Sciences Reaches Target Enrollment ex-China in Phase 3 REGAL Trial of Galinpepimut-S...

  Nov 29, 2023

More

Agriculture Building Materials Cannabis Chemicals Coal Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Forest Products Healthcare Industrials Metals & Mining Gold Industrial Metals & Minerals Silver Real Estate Steel Technology Utilities